187 related articles for article (PubMed ID: 28349547)
1. Larger men have larger prostates: Detection bias in epidemiologic studies of obesity and prostate cancer risk.
Rundle A; Wang Y; Sadasivan S; Chitale DA; Gupta NS; Tang D; Rybicki BA
Prostate; 2017 Jun; 77(9):949-954. PubMed ID: 28349547
[TBL] [Abstract][Full Text] [Related]
2. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
3. Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate.
Rundle A; Jankowski M; Kryvenko ON; Tang D; Rybicki BA
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):898-904. PubMed ID: 23613026
[TBL] [Abstract][Full Text] [Related]
4. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
[TBL] [Abstract][Full Text] [Related]
5. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
[TBL] [Abstract][Full Text] [Related]
6. Obesity and prostate cancer: epidemiology and clinical implications.
Buschemeyer WC; Freedland SJ
Eur Urol; 2007 Aug; 52(2):331-43. PubMed ID: 17507151
[TBL] [Abstract][Full Text] [Related]
7. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL.
Fukushima H; Masuda H; Kawakami S; Ito M; Sakura M; Numao N; Koga F; Saito K; Fujii Y; Yamamoto S; Yonese J; Fukui I; Kihara K
Urology; 2012 Jun; 79(6):1329-34. PubMed ID: 22656412
[TBL] [Abstract][Full Text] [Related]
8. Body mass index as a predictor of prostate cancer: development versus detection on biopsy.
Freedland SJ; Terris MK; Platz EA; Presti JC
Urology; 2005 Jul; 66(1):108-13. PubMed ID: 15992911
[TBL] [Abstract][Full Text] [Related]
9. Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men.
Salgado-Montilla J; Soto Salgado M; Surillo Trautmann B; Sánchez-Ortiz R; Irizarry-Ramírez M
Lipids Health Dis; 2015 Sep; 14():111. PubMed ID: 26377420
[TBL] [Abstract][Full Text] [Related]
10. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
[TBL] [Abstract][Full Text] [Related]
11. Extent of Baseline Prostate Atrophy Is Associated With Lower Incidence of Low- and High-grade Prostate Cancer on Repeat Biopsy.
Freitas DM; Andriole GL; Castro-Santamaria R; Freedland SJ; Moreira DM
Urology; 2017 May; 103():161-166. PubMed ID: 28024967
[TBL] [Abstract][Full Text] [Related]
12. Higher body mass index increases the risk for biopsy-mediated detection of prostate cancer in Chinese men.
Hu MB; Bai PD; Wu YS; Zhang LM; Xu H; Na R; Jiang HW; Ding Q
PLoS One; 2015; 10(4):e0124668. PubMed ID: 25861033
[TBL] [Abstract][Full Text] [Related]
13. Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?
Murphy AB; Nyame YA; Batai K; Kalu R; Khan A; Gogana P; Dixon M; Macias V; Kajdacsy-Balla A; Hollowell CM; Catalona WJ; Kittles R
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):55-60. PubMed ID: 27725729
[TBL] [Abstract][Full Text] [Related]
14. Obesity and prostate cancer: making sense out of apparently conflicting data.
Freedland SJ; Platz EA
Epidemiol Rev; 2007; 29():88-97. PubMed ID: 17478439
[TBL] [Abstract][Full Text] [Related]
15. Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial.
Roehrborn CG; Andriole GL; Wilson TH; Castro R; Rittmaster RS
Eur Urol; 2011 Feb; 59(2):244-9. PubMed ID: 21093145
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?
Liang Y; Ketchum NS; Goodman PJ; Klein EA; Thompson IM
J Urol; 2014 Oct; 192(4):1094-9. PubMed ID: 24747090
[TBL] [Abstract][Full Text] [Related]
17. Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial.
Ploussard G; Nicolaiew N; Marchand C; Terry S; Allory Y; Vacherot F; Abbou CC; Salomon L; de la Taille A
BJU Int; 2013 May; 111(6):988-96. PubMed ID: 23452046
[TBL] [Abstract][Full Text] [Related]
18. Baseline prostate atrophy is associated with lower tumor volume in men with prostate cancer on repeat biopsy.
Moreira DM; Andriole GL; Castro-Santamaria R; Freedland SJ
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):106-112. PubMed ID: 29203895
[TBL] [Abstract][Full Text] [Related]
19. The impact of prior TURP on radical prostatectomy surgical margins: a multicenter analysis.
Gacci M; Simonato A; Lanciotti M; Ennas M; Varca V; Maffezzini M; Imbimbo C; Gontero P; Schiavina R; Carini M; Martorana G; Nicita G; Mirone V; Carmignani G
Urol Int; 2013; 91(1):62-8. PubMed ID: 23735440
[TBL] [Abstract][Full Text] [Related]
20. Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set.
Porcaro AB; Novella G; Cacciamani G; De Marchi D; Corsi P; De Luyk N; Bizzotto L; Processali T; Cerasuolo M; Tamanini I; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Urol Int; 2017; 98(1):22-27. PubMed ID: 27376763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
